News

Specifically, the court has denied petitions requesting appeal from Applera concerning six Enzo patents asserted against Applera and Tropix, thus allowing Enzo’s infringement case to go forward. The

In the studies, reduction in clinical scores and pathology with PRTX-100 were equivalent to the suppression seen in mice treated with etanercept. Etanercept is co-marketed by Amgen and

Actavis believes the deal will leverage its position in the US market. The agreement will concentrate on controlled release products (CR). CR versions of drugs are useful because

The drug specifically mimics the activity of thrombopoietin (TPO), the key hematopoietic growth factor responsible for platelet production. There are currently no approved TPO molecules available but there

The results, which also indicate that chemotherapy may cause long-term brain damage, represent the closest that scientists have come to pinpointing the underlying cause of “chemo brain,” a

Final approval is expected upon expiry of patent protection for Novartis' Voltaren Ophthalmic Solution in October 2007. Upon final approval, diclofenac sodium ophthalmic solution will be the generic

Nycomed will have exclusive commercialization rights in Europe and other select countries, and Durect will retain full ownership of Posidur in the US, Canada, Asia and other countries.

Recent research has suggested that Tamiflu induces hallucinations and abnormal behavior, including self harm, in patients taking the antiviral drug Tamiflu. These reports include children and teenagers, primarily

In an 8-7 vote, with one abstention, panel members said that available data did not demonstrate that Celebrex was safe in treating the disease. However, the regulators decided